Biomea Fusion Inc (BMEA) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

BMEA ranks #5632 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BMEA is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

62 institutions disclose a position in BMEA, but none treat it as a major bet — even Aisling Capital Management LP, its most concentrated holder, allocates just 0.6% of its own portfolio to it.

CFS Investment Advisory Services, LLC has trimmed its BMEA position for two straight quarters, cutting it by $15.2K while still holding $19.8K.

BMEA is down 3.8% today, but institutions show net buying of $2.7M this quarter — a divergence between today's price move and the underlying institutional flow.

BMEA reported a net loss of $32.5M over the trailing twelve months.

• Not yet profitable — net loss of $32.5M over the trailing twelve months
• Net income improved year over year, from -$112.1M to -$32.5M
• Operating cash flow was negative, using $70.4M in cash
• Current ratio of 5.23x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.98x equity — within a conventional range